πŸ‡ΊπŸ‡Έ FDA
Patent

US 9217007

Platinum anticancer agents

granted A61PA61P35/00

Quick answer

US patent 9217007 (Platinum anticancer agents) held by The Regents of the University of California expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00